These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 6304132

  • 1. Characterization of the thyrotropin receptor-adenylate cyclase system in neoplastic human thyroid tissue.
    Clark OH, Gerend PL, Goretzki P, Nissenson RA.
    J Clin Endocrinol Metab; 1983 Jul; 57(1):140-7. PubMed ID: 6304132
    [Abstract] [Full Text] [Related]

  • 2. Thyrotropin binding and adenylate cyclase activation in normal and neoplastic human thyroid tissue: lack of effect of thyroglobulin.
    Clark OH, Gerend PL, Nissenson RA.
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1157-63. PubMed ID: 7076796
    [Abstract] [Full Text] [Related]

  • 3. Relevance of the low and high affinity thyrotropin-binding sites of human thyroid membranes to the stimulation of adenylate cyclase.
    Lefort GP, Amr S, Carayon P, Nisula BC.
    Endocrinology; 1984 Mar; 114(3):1005-11. PubMed ID: 6321134
    [Abstract] [Full Text] [Related]

  • 4. Thyrotropin receptor-adenylate cyclase system in Hurthle cell neoplasms.
    Clark OH, Gerend PL.
    J Clin Endocrinol Metab; 1985 Oct; 61(4):773-8. PubMed ID: 2993348
    [Abstract] [Full Text] [Related]

  • 5. Thyrotropin regulation of adenylate cyclase activity in human thyroid neoplasms.
    Clark OH, Gerend PL.
    Surgery; 1985 May; 97(5):539-46. PubMed ID: 2986305
    [Abstract] [Full Text] [Related]

  • 6. Thyrotropin binding and adenylate cyclase stimulation in thyroid neoplasms.
    Clark OH, Gerend PL, Cote TC, Nissenson RA.
    Surgery; 1981 Aug; 90(2):252-61. PubMed ID: 6266060
    [Abstract] [Full Text] [Related]

  • 7. Polyphloretin phosphate, an antagonist of thyrotropin action: evidence for an interaction with the hormone rather than the receptor.
    Amir SM, Kasagi K, Corretti M, Blank M, Ingbar SH.
    Endocrinology; 1985 Sep; 117(3):860-8. PubMed ID: 2990874
    [Abstract] [Full Text] [Related]

  • 8. Thyrotropin receptor-adenylate cyclase function in human thyroid neoplasms.
    Saltiel AR, Powel-Jones CH, Thomas CG, Nayfeh SN.
    Cancer Res; 1981 Jun; 41(6):2360-5. PubMed ID: 6263464
    [Abstract] [Full Text] [Related]

  • 9. TSH binding correlates with TSH-stimulated thyroid adenylate cyclase activity in human thyroid tissues.
    Duh QY, Siperstein AE, Miller RA, Smeds S, Clark OH.
    Surgery; 1989 Dec; 106(6):967-73; discussion 973-4. PubMed ID: 2588124
    [Abstract] [Full Text] [Related]

  • 10. Binding of bovine thyrotropin to receptors in rat testis and its interaction with gonadotropins.
    Amir SM, Sullivan RC, Ingbar SH.
    Endocrinology; 1978 Jul; 103(1):101-11. PubMed ID: 217636
    [Abstract] [Full Text] [Related]

  • 11. Absence of high-affinity binding sites for beta-adrenergic blockers and lack of adenyl cyclase stimulation to beta-adrenergic stimulators in most normal and adenomatous human thyroid tissues.
    Goretzki PE, Wahl RA, Branscheid D, Roeher HD.
    Surgery; 1984 Dec; 96(6):1001-8. PubMed ID: 6150553
    [Abstract] [Full Text] [Related]

  • 12. Positive regulation of the guinea pig thyrotropin receptor.
    Davies TF.
    Endocrinology; 1985 Jul; 117(1):201-7. PubMed ID: 2988915
    [Abstract] [Full Text] [Related]

  • 13. Evidence that partially desialylated variants of human chorionic gonadotropin (hCG) are the factors in crude hCG that inhibit the response to thyrotropin in human thyroid membranes.
    Hoermann R, Amir SM, Ingbar SH.
    Endocrinology; 1988 Sep; 123(3):1535-43. PubMed ID: 3402396
    [Abstract] [Full Text] [Related]

  • 14. Inhibition by certain plant extracts of the binding and adenylate cyclase stimulatory effect of bovine thyrotropin in human thyroid membranes.
    Auf'mkolk M, Ingbar JC, Amir SM, Winterhoff H, Sourgens H, Hesch RD, Ingbar SH.
    Endocrinology; 1984 Aug; 115(2):527-34. PubMed ID: 6745167
    [Abstract] [Full Text] [Related]

  • 15. Thyrotropin (TSH) receptor and adenylate cyclase activity in human thyroid tumors: absence of high affinity receptor and loss of TSH responsiveness in undifferentiated thyroid carcinoma.
    Abe Y, Ichikawa Y, Muraki T, Ito K, Homma M.
    J Clin Endocrinol Metab; 1981 Jan; 52(1):23-8. PubMed ID: 6256403
    [Abstract] [Full Text] [Related]

  • 16. Interaction between thyrotropin (TSH) binding inhibitor immunoglobulins (TBII) and soluble TSH receptors in fat cells.
    Kishihara M, Nakao Y, Baba Y, Kobayashi N, Matsukura S, Kuma K, Fujita T.
    J Clin Endocrinol Metab; 1981 Apr; 52(4):665-70. PubMed ID: 6110672
    [Abstract] [Full Text] [Related]

  • 17. Thyrotropin binding to cultured lymphocytes and thyroid cells.
    Pekonen F, Weintraub BD.
    Endocrinology; 1978 Nov; 103(5):1668-77. PubMed ID: 34508
    [Abstract] [Full Text] [Related]

  • 18. Comparison of binding of bovine and human thyroid-stimulating hormone to receptor sites on human thyroid membranes.
    Kermode JC, Thompson BD, Edmonds CJ.
    J Endocrinol; 1981 Feb; 88(2):205-17. PubMed ID: 6259266
    [Abstract] [Full Text] [Related]

  • 19. Regulation of thyroid adenylate cyclase: guanyl nucleotide modulation of thyrotropin receptor-adenylate cyclase function.
    Saltiel AR, Powell-Jones CH, Thomas CG, Nayfeh SN.
    Endocrinology; 1981 Nov; 109(5):1578-89. PubMed ID: 6271536
    [Abstract] [Full Text] [Related]

  • 20. The carbohydrate moiety of bovine thyrotropin is essential for full bioactivity but not for receptor recognition.
    Amir SM, Kubota K, Tramontano D, Ingbar SH, Keutmann HT.
    Endocrinology; 1987 Jan; 120(1):345-52. PubMed ID: 3023032
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.